FDA Drugs (New Approvals & NDA)Original article
Sunny Pharmtech, Inc. Issues Voluntary Nationwide Recall of Cyclophosphamide for Injection, USP to the User Level Due to the Presence of Particulate Matter
RegulatoryCyclophosphamide for Injection, USPNegative
AI Analysis
Summary
Sunny Pharmtech voluntarily recalls three lots of Cyclophosphamide for Injection due to the presence of steel particulate matter. No adverse events or injuries have been reported to date.
Outcome Details
Voluntary nationwide recall due to presence of steel particulate matter in three lots (1g/vial and 2g/vial)
Importance:5/10
Sentiment:
-0.80
recallproduct qualityparticulate mattermanufacturingcyclophosphamide
Read the original article
Published by FDA Drugs (New Approvals & NDA) on July 24, 2026 3:32 PM